Drug update

Reuptake inhibitors for depression

Bill Lyndon



The newer neurotransmitter reuptake inhibitors, because of their greater selectivity, have significant advantages in safety and side effects compared with the original reuptake inhibitors, the tricyclics.

Article Extract

The management of depression advanced greatly with the development of antidepressant agents based on neurotransmitter reuptake inhibition and, more recently, the development of reuptake inhibitors selective for specific neurotransmitters. These newer antidepressants have fewer side effects and less toxicity than the older agents. The pharmacology of the reuptake inhibitors, and particularly the newer drugs, is discussed in this article.